Stifel Cuts Boston Scientific Price Target by 12% to $110
Stifel trimmed Boston Scientific’s 12% price target to $110 from $125, marking a $15 reduction. The move reflects revised expectations for the company’s medical device segment and could pressure near-term investor sentiment.
1. Analyst Price Target Reduction
Stifel analysts reduced their one-year price target for Boston Scientific to $110 from $125, a 12% cut representing tempered expectations for the company’s upcoming earnings and growth trajectory.
2. Implications for Investor Sentiment
Such a sizable downward adjustment may weigh on investor confidence, potentially leading to increased volatility in Boston Scientific’s share price as market participants reassess valuation.
Related News
GOOG
Google Secures Tens of Thousands of MWh Storage as U.S. Energy Storage Hits Q1 Record
GOOG•
NVDA
Nvidia Q2 Profit Jumps 200% with Revenue Up 85%
NVDA•
META
Meta Secures Tens of Thousands MWh Storage Deals, Cuts 10% Workforce
META•
NTES
NetEase Q1 Revenue Hits RMB30.6 Billion; Gross Profit Jumps 14.8%
NTES•
PII
Polaris Launches $9,999 RANGER 500 and Installs 8,000 m² Solar Array
PII•
Sources
F